Recent Blog Articles

Harvard Health Blog

Join the discussion with experts from Harvard Health Publishing and others like you on a variety of health topics, medical news, and views.


A patient’s story: Overcoming incontinence

Published March 11, 2009

How one man persisted for almost two years in an effort to remedy one of the most bothersome possible side effects of prostate cancer treatment, and what men facing therapeutic decisions can learn from his experience.

Androgen-independent prostate cancer

Published March 11, 2009

When cancer advances despite primary hormone therapy

We often hear the term prostate cancer and assume it is one disease. Practically speaking, it is. On a molecular level, however, scientists are revealing a far more complex picture. Cancer has an innate ability to adapt to its surroundings. As it progresses, cancer cells tend to change, morphing to a point where the differences between tumor cells can be dramatic. That’s why some researchers believe late-stage prostate cancer is more accurately described as a mix of cancer cell types.

How to handle a relapse after treatment for prostate cancer

Published March 11, 2009

Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are.

Answering key clinical questions

Published March 11, 2009

An interview with renowned urology researcher E. David Crawford, M.D., about the state of clinical trials on prostate health

Can hormone therapy extend the lives of men with advanced prostate cancer? Might a drug traditionally prescribed to treat benign prostatic hyperplasia (BPH) help prevent prostate cancer? Does a short course of hormone therapy prior to a radical prostatectomy prevent or delay cancer’s return?

Promising technologies for the treatment of prostate cancer

Published March 11, 2009

Marc B. Garnick, M.D., provides an overview of possible treatments that need more study, including cryotherapy, HIFU, and focal therapies.

Possible complications of hormone therapy

Published March 10, 2009

Three Harvard-affiliated physicians discuss the impact that hormone therapy can have on bones and cardiovascular health.

Intermittent hormone therapy for prostate cancer

Published March 10, 2009

Marc B. Garnick, M.D., discusses this therapy, which aims to strike a balance between effective treatment and quality of life.

Hormone therapy for prostate cancer

Published March 10, 2009

Marc Garnick, M.D., Editor in Chief of the Annual Report on Prostate Diseases, discusses what you need to know about therapy: when it’s used, what your options are, and what doctors disagree about.

When to consider active surveillance

Published March 10, 2009

Which men are candidates for active surveillance? Some studies suggest that men with low risk cancer should consider active surveillance over traditional treatment, but the evidence is mixed.

Early-stage prostate cancer: Treat or wait?

Published March 10, 2009

When it comes to early-stage prostate cancer, there is no evidence that one treatment is better than another or that any treatment at all actually prolongs life. If you are diagnosed with early-stage prostate cancer, you’ll want to consider factors such as your values, your quality of life, and the potential side effects of various treatments before making a decision.

Getting a closer look at prostate cancer with molecular imaging

Published March 10, 2009

Molecular imaging may help determine the location and extent of cancer — and point to the best treatment — especially metastatic cancers too small to be detected by CT or MRI scanning.

Understanding your prostate pathology report

Published March 10, 2009

Not all pathology reports are created equal. In fact, they can vary widely even within a single institution. Learn what your report should contain, what it means, and why asking questions about it can lead to better care.

Improved magnetic resonance imaging (MRI) may aid detection of prostate cancer

Published March 10, 2009

Dr. Neil Rofsky, of Harvard’s Beth Israel Deaconess Medical Center, discusses MRI technology, which patients might benefit from it, and the relative advantages and disadvantages of MRI as compared with other imaging modalities.